Contents

Search


type 2 (mixed) cryoglobulinemia

Disease characterized by recurrent episodes of purpura, arthralgias, weakness & multiorgan involvement. Similar to type 3 (mixed) cryoglobulinemia. Etiology: 1) frequently associated with: a) chronic infection b) hepatitis B c) hepatitis C (> 80-90%) d) HIV1 [3] e) autoimmune disorders 1] systemic lupus erythematosus 2] vasculitis 3] Sjogren's syndrome f) lymphoproliferative disorders 1] Waldenstrom's macroglobulinemia 2] B-cell non_Hodkins's lymphoma, chronic lymphocytic leukemia 2) essential or idiopathic cryoglobulinemia is generally due to hepatitis C [3] Pathology: 1) deposition of immune complexes a) polyclonal immunoglobulins + monoclonal IgM or IgA [3] b) generally IgM kappa with anti-immunoglobulin specificity (rheumatoid factor) c) rheumatoid factor is monoclonal* d) other components: 1] hepatitis C antigen 2] other infectious agents 3] cellular & nuclear antigens 4] complement 2) present in smaller quantities than type 1 globulins (50-500 mg/dL) 3) cryoglobulins disappear when infection resolves 4) non-systemic, small vessel vasculitis - occurs secondary to immune complex deposition & complement fixation on surface of endothelial cells 5) histopathology of vascular structures similar to leukocytoclastic vasculitis * Distinguishes type 2 from type 3 Clinical manifestations: 1) recurrent symptoms 2) common a) local & systemic small vessel vasculitis - lower extremity palpable purpura 60% - urticaria - cutaneous ulceration NOT a feature - skin ulcers & necrosis [3] - CNS vasculitis [3] - gastrointestinal vasculitis b) arthralgias & arthritis (15-20%) c) peripheral neuropathy 5% d) Raynaud's phenomenon 40% 5) acrocyanosis [3] e) digital ischemia [3] 3) less common manifestations a) focal segmental sclerosing glomerulonephritis b) membranoproliferative glomerulonephritis c) hepatomegaly d) pulmonary manifestations (uncommon) - diffuse pulmonary vasculitis - alveolar hemorrhage - bronchiolitis obliterans (BOOP) - bronchiectasis - pneumonitis - pulmonary hemorrhage e) serositis: pleurisy, pericarditis f) thyroiditis Laboratory: 1) blood collection & specimen processing a) blood collected in pre-warmed tubes b) kept at 37 degrees during clotting to keep cryoglobulins from precipitating with clot c) serum separated from clot at 37 degrees d) incubation at 4 degrees C for 72 hours 2) cryoglobulins in serum/plasma - trace amounts of cryoglobulins may be found in normal individuals 3) serum protein electrophoresis & immunofixation elecrophoresis - polyclonal IgG, monoclonal IgM rheumatoid factor [3] 4) serum complement levels (C1q-C4, CH50) are generally decreased 5) erythrocyte sedimentation rate is generally increased 6) rheumatoid factor is generally positive (monoclonal IgM) 7) hepatitis serology a) frequently positive for hepatitis C b) may be positive for hepatitis B 8) biopsy of vascular structures Complications: 1) glomerulonephritis secondary to deposition of immune complexes (most common) a) focal segmental glomerulonephritis b) membranoproliferative glomerulonephritis [3,5] 2) hepatosplenomegaly 3) hepatic cirrhosis 4) pneumonitis 5) pulmonary hemorrhage 6) serositis a) pleurisy b) pericarditis 7) thyroiditis 8) lymphoproliferative disorder Management: 1) therapy directed at underlying disease - ledipasvir & sofosbuvir for treatment of hepatitis C [3] 2) idiopathic or essential cryoglobulinemia a) prednisone b) other immunosuppressive agents

Related

cryoglobulin

General

cryoglobulinemia (cryoglobulinemic vasculitis)

References

  1. Manual of Medical Therapeutics, 28th ed, Ewald & McKenzie (eds), Little, Brown & Co, Boston, 1995, pg 527
  2. Mayo Internal Medicine Board Review, 1998-99, Prakash UBS (ed) Lippincott-Raven, Philadelphia, 1998, pg 610, 784, 849
  3. Medical Knowledge Self Assessment Program (MKSAP) 11, 14, 15, 16, 17, 18. American College of Physicians, Philadelphia 1998, 2006, 2009, 2012, 2015, 2018.
  4. Brahn E, Scoville CD Biochemical markers of disease activity. Baillieres Clin Rheumatol 1988 2:153 PMID: 2458192
  5. Roccatello D, Fornasieri A, Giachino O et al Multicenter study on hepatitis C virus-related cryoglobulinemic glomerulonephritis. Am J Kidney Dis. 2007 Jan;49(1):69-82. PMID: 17185147
  6. Dammacco F, Sansonno D. Therapy for hepatitis C virus-related cryoglobulinemic vasculitis. N Engl J Med. 2013 Sep 12;369(11):1035-45. PMID: 24024840